Saturday, October 25th, 2008
Johns Hopkins and National Fibromyalgia Association Launch - Genetic Engineering News
The Johns Hopkins University School of Medicine, The Institute for Johns Hopkins Nursing and the National Fibromyalgia Association announced today the launch of the Fibromyalgia Circle of Care Initiative at the ACR/ARHP Annual Scientific Meeting
Study: Placebos often prescribed - Seattle Times
Half of all U.S. doctors responding to a nationwide survey say they regularly prescribe placebos to patients. The results trouble medical ethicists, who say more research is needed to determine whether doctors must deceive patients for placebos to
Health Calendar: Taking care of yourself, others - Dallas Morning News
Discover ways to engage your child’s natural abilities through each developmental stage, from birth to age 3, Thursday at MetroMoms, featuring PlayWisely founder Patty Hannan, a former national-level gymnast and NASA research participant. Cost for
Free workshop about fibromyalgia - Danbury News-Times
NEW MILFORD - Chiropractor Frank McNeary will give a free workshop, “Understanding Fibromyalgia,” Oct. 28 from 7 to 8 p.m. at Italia Mia Restaurant, 233 Danbury Road. Food and beverages will be served. Register by calling (203) 556-3595
Pain you can’t explain: It might be Fibromyalgia - Frost Illustrated
I have many female patients come to my office complaining about pain in their muscles. They have been to several other doctors and have received medication for the pain without results. The general over-the-counter medications, including prescribed
FDA Defers Final Action on milnacipran New Drug Application - MSN MoneyCentral
NEW YORK and SAN DIEGO , Oct. 20 /PRNewswire-FirstCall/ — Forest Laboratories, Inc. FRX and Cypress Bioscience, Inc. CYPB (the “Companies”) today announced that the U.S. Food and Drug Administration (FDA) has advised the Companies that it was not
UPDATE 1-Forest, Cypress fibromyalgia drug delayed at FDA - Reuters
BOSTON, Oct. 20 (Reuters) - Forest Laboratories Inc (FRX.N: Quote , Profile , Research , Stock Buzz ) and Cypress Bioscience Inc (CYPB.O: Quote , Profile , Research , Stock Buzz ) said on Monday the U.S. Food and Drug Administration was not able to